Roy Subhasree, Chatterjee Somdatta, Bhattacharjee Amrita, Chattopadhyay Pinaki, Saha Bijan, Dutta Shanta, Basu Sulagna
Division of Bacteriology, Indian Council of Medical Research (ICMR)-National Institute of Cholera and Enteric Diseases, Kolkata, India.
Department of Neonatology, Institute of Post-Graduate Medical Education and Research, Kolkata, India.
Front Microbiol. 2021 Mar 11;12:602724. doi: 10.3389/fmicb.2021.602724. eCollection 2021.
This study investigates susceptibility toward three fluoroquinolones (ciprofloxacin, levofloxacin, moxifloxacin), multiple fluoroquinolone-resistance mechanisms, and epidemiological relationship of neonatal septicaemic . Previous studies on fluoroquinolone resistance in focused primarily on ciprofloxacin susceptibility and assessed a particular mechanism of resistance; a more holistic approach was taken here. Epidemiological relationship was evaluated by Multi Locus Sequence Typing. Minimum Inhibitory Concentrations of fluoroquinolones was determined with and without efflux pump inhibitors. Overexpression of efflux pumps, resistance-nodulation-cell-division (RND)-type, and multidrug and toxic compound extrusion (MATE)-type efflux pumps were evaluated by reverse transcriptase-qPCR. Mutations within regulatory proteins (AdeRS, AdeN, and AdeL) of RND-pumps were examined. Chromosomal mutations, presence of and ' were investigated. were highly diverse as 24 sequence-types with seven novel STs (ST-1440/ST-1441/ST-1481/ST-1482/ST-1483/ST-1484/ST-1486) were identified among 47 High resistance to ciprofloxacin (96%), levofloxacin (92%), and particularly moxifloxacin (90%) was observed, with multiple mechanisms being active. Resistance to 4 generation fluoroquinolone (moxifloxacin) in neonatal isolates is worrisome. Mutations within GyrA (S83L) and ParC (S80L) were detected in more than 90% of fluoroquinolone-resistant (FQRAB) spread across 10 different clonal complexes (CC1/CC2/CC10/CC25/CC32/CC126/CC149/CC216/CC218/CC513). Efflux-based FQ resistance was found in 65% of FQRAB with ≥2 different active pumps in 38% of strains. Overexpression of was highest (2.2-34-folds) followed by , , and . Amino acid changes in the regulators (AdeRS/AdeN/AdeL) either as single or multiple substitutions substantiated the overexpression of the pumps. Diverse mutations within AdeRS were detected among different CCs whereas mutations within AdeN linked to CC10 and CC32. Chromosomal mutations and active efflux pumps were detected simultaneously among 64% of FQRAB. Presence of was also high (74% of FQRAB) but were absent. As most FQRABs had chromosomal mutations, this was considered predominant, however, isolates where pumps were also active had higher MIC values, establishing the critical role of the efflux pumps. The high variability of FQ susceptibility among FQRAB, possessing the same set of mutations in , , and efflux pump regulators, was also noted. This reveals the complexity of interpreting the interplay of multiple resistance mechanisms in .
本研究调查了新生儿败血症对三种氟喹诺酮类药物(环丙沙星、左氧氟沙星、莫西沙星)的敏感性、多种氟喹诺酮耐药机制以及流行病学关系。以往关于氟喹诺酮耐药性的研究主要集中在环丙沙星敏感性方面,并评估了一种特定的耐药机制;本研究采用了更全面的方法。通过多位点序列分型评估流行病学关系。在有和没有外排泵抑制剂的情况下测定氟喹诺酮类药物的最低抑菌浓度。通过逆转录定量聚合酶链反应评估外排泵、耐药结节化细胞分裂(RND)型和多药及有毒化合物外排(MATE)型外排泵的过表达情况。检查RND泵调节蛋白(AdeRS、AdeN和AdeL)内的突变。研究染色体突变、质粒的存在情况。菌株高度多样,在47株菌株中鉴定出24种序列类型以及7种新的STs(ST-1440/ST-1441/ST-1481/ST-1482/ST-1483/ST-1484/ST-1486)。观察到对环丙沙星(96%)、左氧氟沙星(92%),尤其是莫西沙星(90%)的高耐药性,多种耐药机制同时起作用。新生儿分离株对四代氟喹诺酮(莫西沙星)的耐药性令人担忧。在分布于10种不同克隆复合体(CC1/CC2/CC10/CC25/CC32/CC126/CC149/CC216/CC218/CC513)的90%以上耐氟喹诺酮类鲍曼不动杆菌(FQRAB)中检测到GyrA(S83L)和ParC(S80L)内的突变。在65%的FQRAB中发现基于外排的氟喹诺酮耐药性,38%的菌株中有≥2种不同的活性泵。qepA的过表达最高(2.2至34倍),其次是norA、mepA和adeABC。调节蛋白(AdeRS/AdeN/AdeL)中的氨基酸变化,无论是单个还是多个取代,都证实了泵的过表达。在不同的CCs中检测到AdeRS内的多种突变,而AdeN内的突变与CC10和CC32相关。在64%的FQRAB中同时检测到染色体突变和活性外排泵。质粒的存在也很常见(74%的FQRAB),但未检测到整合子。由于大多数FQRAB都有染色体突变,这被认为是主要的,然而,外排泵也活跃的分离株具有更高的MIC值,确立了外排泵的关键作用。还注意到FQRAB中氟喹诺酮敏感性的高度变异性,它们在gyrA、parC和外排泵调节蛋白中具有相同的一组突变。这揭示了解释鲍曼不动杆菌中多种耐药机制相互作用的复杂性。